Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Invesco Pharmaceuticals ETF (PJP)
USD117.60
-0.95 (-0.80%)
AMEX USD US Equity
NAV
USD 118.51
-0.77% vs NAV
as of 2026-07-13
AUM
USD 357.90M
TER
0.57%
Yield (TTM)
0.91%
Distribution
Distributing · Quarterly
52-week range
80.73 – 122.24
Holdings
34
Issuer
Invesco
About this ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
ISIN
US46137V6627
Issuer
Invesco
Domicile
US
Inception
2005-06-23
Asset class
Equity
Price
Top 10 holdings
| AbbVie Inc ABBV | 5.53% |
| Johnson & Johnson JNJ | 5.31% |
| Eli Lilly & Co LLY | 5.31% |
| Abbott Laboratories ABT | 5.15% |
| Amgen Inc AMGN | 5.14% |
| Merck & Co Inc MRK | 4.91% |
| Gilead Sciences Inc GILD | 4.62% |
| Pfizer Inc PFE | 4.45% |
| Corcept Therapeutics Inc CORT | 4.07% |
| Ligand Pharmaceuticals Inc LGND | 3.59% |
Sector mix
Price chart
USD117.60
-0.95 (-0.80%)
Loading historical data…
Returns
| 1 month | +5.22% |
| 3 months | +13.56% |
| 6 months | +11.49% |
| Year to date | +12.49% |
| 1 year | +40.74% |
| 3 years (ann.) | +16.54% |
| 5 years (ann.) | +7.62% |
| 10 years (ann.) | +6.38% |
Risk profile
| Volatility (1y, ann.) | 16.97% |
| Sharpe (1y) | 2.10 |
| Sharpe (3y) | 1.04 |
| Sortino (1y) | 3.80 |
| Max drawdown (1y) | -9.72% |
| Max drawdown (5y) | -18.75% |
| Max drawdown (full) | -42.36% |
| Beta vs S&P 500 (1y) | 0.49 |
| Correlation vs S&P 500 (1y) | 0.36 |
Technical outlook as of 2026-07-13
Day Score (bias 0-100, not a probability)
60
P(gain) 22 sessions — probability
54%
VaR 95% (daily)
-1.79%
CVaR 95% (daily)
-2.65%
GARCH vol forecast (22d)
1.16%
Market regime (Markov)
Lateral
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Top-10 concentration
48.1%
Effective holdings
26
Disclosed positions
34
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Loading map…
Cost vs. peers
PJP
0.57%
Equity median
0.39%
Cheapest in class BKLC
0.00%
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Distributing share class Income is paid out to shareholders.
| Ex-date | Payment | Amount |
|---|---|---|
| 2026-06-22 | 2026-06-26 | USD 0.2733 |
| 2026-03-23 | 2026-03-27 | USD 0.3090 |
| 2025-12-22 | 2025-12-26 | USD 0.2463 |
| 2025-09-22 | 2025-09-26 | USD 0.2363 |
| 2025-06-23 | 2025-06-27 | USD 0.2668 |
| 2025-03-24 | 2025-03-28 | USD 0.2729 |
| 2024-12-23 | 2024-12-27 | USD 0.2232 |
| 2024-09-23 | 2024-09-27 | USD 0.2004 |
| 2024-06-24 | 2024-06-28 | USD 0.2105 |
| 2024-03-18 | 2024-03-22 | USD 0.1695 |
| 2023-12-18 | 2023-12-22 | USD 0.1913 |
| 2023-09-18 | 2023-09-22 | USD 0.2013 |
| 2023-06-20 | 2023-06-23 | USD 0.1756 |
| 2023-03-20 | 2023-03-24 | USD 0.2024 |
| 2022-12-19 | 2022-12-23 | USD 0.1683 |
| 2022-09-19 | 2022-09-23 | USD 0.1693 |
| 2022-06-21 | 2022-06-30 | USD 0.2068 |
| 2022-03-21 | 2022-03-31 | USD 0.2015 |
| 2021-12-20 | 2021-12-31 | USD 0.1845 |
| 2021-09-20 | 2021-09-30 | USD 0.1749 |
| 2021-06-21 | 2021-06-30 | USD 0.1478 |
| 2021-03-22 | 2021-03-31 | USD 0.1526 |
| 2020-12-21 | 2020-12-31 | USD 0.1305 |
| 2020-09-21 | 2020-09-30 | USD 0.1166 |
| 2020-06-22 | 2020-06-30 | USD 0.1556 |
| 2020-03-23 | 2020-03-31 | USD 0.1360 |
| 2019-12-23 | 2019-12-31 | USD 0.1619 |
| 2019-09-23 | 2019-09-30 | USD 0.1492 |
| 2019-06-24 | 2019-06-28 | USD 0.1282 |
| 2019-03-18 | 2019-03-29 | USD 0.0606 |
| 2018-12-24 | 2018-12-31 | USD 0.3644 |
| 2018-09-24 | 2018-09-28 | USD 0.1592 |
| 2018-06-18 | 2018-06-29 | USD 0.1154 |
| 2018-03-19 | 2018-03-29 | USD 0.0563 |
| 2017-12-18 | 2017-12-29 | USD 0.1010 |
| 2017-09-18 | 2017-09-29 | USD 0.1228 |
| 2017-06-16 | 2017-06-30 | USD 0.1559 |
| 2017-03-17 | 2017-03-31 | USD 0.0368 |
| 2016-12-16 | 2016-12-30 | USD 0.2070 |
| 2016-09-16 | 2016-09-30 | USD 0.1070 |
ESG profile
Derived from holdings
covers 94.6% of the portfolio by weight
(26 scored constituents)
Environmental
64.2
class avg 63.0
Social
64.3
class avg 62.3
Governance
64.9
class avg 64.9
Total ESG
64.5
class avg 63.4
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Vanguard Value ETF VTV | 0.03% | 245.00B | 7.9% |
| State Street SPDR Portfolio S&P 500 ETF SPYM | 0.02% | 159.32B | 4.9% |
| iShares Core S&P 500 UCITS ETF CSSPX.MI | 0.07% | 151.54B | 4.9% |
| iShares Core S&P 500 UCITS ETF SXR8.DE | 0.07% | 151.54B | 4.9% |
| iShares Core S&P 500 UCITS ETF CSPX.L | 0.07% | 151.69B | 4.9% |
